ARCHIVES

New Compounds To Treat Gleevec-Resistant CML

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Two Cooperative Groups Renamed ECOG-ACRIN

September 23, 2011

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

July 3, 1981

CCOP Review Completed; 72 Applications Submitted, 23 More For Minority CCOP

December 1, 1989

In Brief: Breast Cancer Cells To Be Studied In Space; GrieshaberTo Head Drug Discovery Program

January 30, 1998

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

February 17, 1989

Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA

May 23, 1986